Newsby HottubFor agents

WCVB-TV

FDA orders manufacturers to disclose risk of developing eye disease on GLP-1 labels

Dr. Ali Raja, the chair of emergency medicine at Mass General Brigham, said that NAION is a sudden, painless loss of vision, which the FDA announced is now a possible side effect of certain GLP-1s.

Add to CRM by Hottub

Everyone in this article who could become a relationship. Add opens CRM by Hottub's form, filled in; nothing is saved until you press Add there.